v3.25.4
Consolidated Statements of Cash Flows
 12 Months Ended
Apr. 30, 2025
USD ($)
Apr. 30, 2025
SGD ($)
Apr. 30, 2024
SGD ($)
Apr. 30, 2023
SGD ($)
Cash flows from operating activities        
Profit before income tax $ 19,098 $ 24,929 $ 2,023,322 $ 821,266
Adjustments for:        
Fair value changes on financial assets at fair value through profit or loss (14,063) (18,358) (7,280) (5,247)
Unrealized foreign exchange difference 18,586 24,265 (413) 3,716
Depreciation of property, plant and equipment 65,638 85,684 102,990 118,896
Gain on disposal of plant and equipment (2,015) (2,631)
Insurance premium charged to profit or loss 64,412
Finance costs 69,492 90,715 68,167 47,363
Allowance for expected credit losses for trade and other receivables and contract assets 3,897 5,087 89,367 172,821
Reversal of onerous losses recognized on construction projects (130,343) (1,837,483)
Operating cash flows before working capital changes 160,633 209,691 2,210,222 (678,668)
Changes in working capital:        
Contract assets (604,118) (788,615) (848,332) 635,037
Trade and other receivables 262,383 342,515 2,103,078 700,616
Trade and other payables (152,569) (199,163) (2,295,686) 2,906,525
Contract liabilities (328,370) (428,654) (497,620) (2,567,382)
Cash generated from/(used in) operations (662,041) (864,226) 671,662 996,128
Income tax paid (47,353) (61,815) (61,845)
Net cash generated from/(used in) operating activities (709,394) (926,041) 609,817 996,128
Cash flows from investing activities        
 Payment of initial public offering costs (334,985) (437,290)
Purchase of property, plant and equipment (14,917) (19,472) (31,381) (15,548)
Proceeds from disposal of plant and equipment 3,064 4,000
Purchase of keyman life’s insurance (92,177)
Net cash used in investing activities (346,838) (452,762) (123,558) (15,548)
Cash flows from financing activities        
Repayment of bank borrowings (418,922) (546,861) (399,174) (556,654)
Proceeds from bank borrowings 905,139 1,181,568 400,000
Repayment of lease liabilities (28,027) (36,587) (31,906) (86,879)
Proceeds from issuance of ordinary shares in a subsidiary under common control 153,210 200,000 250,000 350,000
Amount due to a director 361,662 472,113
Dividend paid (766,049) (1,000,000) (450,000) (250,000)
Net cash (used in)/generated from financing activities 207,013 270,233 (231,080) (543,533)
Net change in cash and cash equivalents (849,219) (1,108,570) 255,179 437,047
Cash and cash equivalents at beginning of year 1,431,332 1,868,461 1,613,282 1,176,235
Cash and cash equivalents at end of year $ 582,113 $ 759,891 $ 1,868,461 $ 1,613,282